Search Within

Hikmat Al-Ahmadie

  1. "Merve Basar Yerebakan"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (4)
Groups
  1. Department of Medicine (14)
  2. Department of Pathology and Laboratory Medicine (14)
  3. Genitourinary Oncology Service (14)
  4. Graduate Medical Education (14)
  5. Solid Tumor Oncology Division (14)
  6. GSK Faculty (13)

More Groups

People
  1. Merve Basar Yerebakan (14)
  2. David Solit (13)
  3. Gopakumar Iyer (11)
  4. Judy Sarungbam (11)
  5. Anuradha Gopalan (10)
  6. Jie-Fu Chen (10)

More People

Years
  1. 2025 (6)
  2. 2024 (5)
  3. 2023 (3)
Publications
  1. Laboratory Investigation (6)
  2. Urologic Oncology: Seminars and Original Investigations (3)
  3. European Urology (2)
  4. Modern Pathology (2)
  5. Nature Communications (1)
Publishers
  1. Nature Publishing Group (7)
  2. Elsevier Inc. (3)
  3. Elsevier Science, Inc. (2)
  4. Nature Research (2)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
    Journal Article

    Chang, K.; Delavan, H. M.; Yip, E.; Kasap, C.; Zhu, J.; Lodha, R.; Liao, S. Y.; Berman, S. C.; Carretero-Gonzalez, A.; Basar, M.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma
    Journal Article

    Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Comprehensive molecular, pathological, and clinical characterization of clear cell adenocarcinoma of the urinary tract
    Journal Article

    Rammal, R.; Koll, F. J.; Chen, Z.; Tallman, J. E.; Alam, S. M.; Eichholz, J. E.; Chatila, W.; Agbamu, T.; Lenis, A. T.; Basar, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Molecular and immunohistochemical characterization of urothelial carcinomas with trophoblastic differentiation
    Meeting Abstract

    George, R.; Basar, M.; Tallman, J.; Yol, C.; Kuo, F.; Koll, F.; Reis, H.; Mehra, R.; Chen, J. F.; Sarungbam, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Correlation of NECTIN4 amplification and expression with response to enfortumab vedotin (EV) treatment in locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Yol, C.; Irawan, H.; Sternschuss, M.; Gupta, A.; Bent, E.; Basar, M.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Transcriptional analysis of bladder cancer histologic subtypes reveals novel drug target heterogeneity
    Meeting Abstract

    Tallman, J. E.; Kuo, F.; Koll, F.; Alam, S. M.; Basar, M.; Luo, J.; Gao, S. P.; Tang, X.; Yol, C.; Gokturk, G.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Genomic and clinical characterization of non-invasive papillary urothelial carcinoma
    Meeting Abstract

    Gurbuz, B. C.; Caraballo, B.; Tallman, J.; Koll, F.; Basar, M.; Chen, J. F.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
    Meeting Abstract

    Koll, F. J.; Basar, M.; Chen, Z.; Tin, A. L.; Alam, S. M.; Tallman, J. E.; Clinton, T. N.; Whiting, K.; Chen, J. F.; Sarungbam, J.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Carcinoma in situ and urinary cytology as an indicator of minimal residual disease in patients with non-muscle invasive bladder cancer treated with BCG
    Meeting Abstract

    Katims, A. B.; D'Souza, N.; De Jesus Escaño, M. R.; Gokturk, G.; Basar, M.; Solit, D. B.; Iyer, G.; Bochner, B. H.; Goh, A.; Donahue, T. A.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save